Clinical Trials Browser

Phase 3 × INDUSTRY × Non-Squamous Non-Small Cell Lung Cancer × Clear all

NCT06847334 2025-02-26

A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX17 Vs. Keytruda® in the First-Line Treatment of Advanced Non-squamous Non-small Cell Lung Cancer

Phase 3 Not yet recruiting

Non-Squamous Non-Small Cell Lung Cancer

NCT03802240 2023-11-27

Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure

Phase 3 Completed

Non-Squamous Non-Small Cell Lung Cancer

NCT02008227 2019-12-20

OAK

Phase 3 Completed

1,225 enrolled 32 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01351415 2017-09-18

A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)

Phase 3 Completed

485 enrolled 15 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01456325 2016-11-02

A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)

Phase 3 Completed

Non-Squamous Non-Small Cell Lung Cancer

NCT01887886 2016-11-02

A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating Epidermal Growth Factor Receptor (EGFR) Mutation

Phase 3 Completed

Non-Squamous Non-Small Cell Lung Cancer

NCT01328951 2016-10-28

A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy

Phase 3 Completed

643 enrolled 16 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT00961415 2016-02-22

AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer

Phase 3 Completed

376 enrolled 14 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT00883779 2015-12-14

A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Phase 3 Completed

451 enrolled 23 charts

Non-Squamous Non-Small Cell Lung Cancer